CoverageForm 410-K10-Q8-K13D13G13F

BIAF Bioaffinity Technologies, Inc. - 8-K

Filed May 27, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001493152-26-025338
8.019.01

Item 8.01 - Other Events

68 words

Item
8.01. Other Events.

On
May 27, 2026, bioAffinity Technologies, Inc., a Delaware corporation, issued a press release announcing that it has received notification
of allowance from the Mexican Institute of Industrial Property for a patent application related to methods of predicting the likelihood
of lung cancer using flow cytometry.

A
copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 - Financial Statements and Exhibits

37 words

Item
9.01. Financial Statements and Exhibits.

(d)

Exhibits.

Exhibit

Number

Description

99.1

Press Release issued by bioAffinity Technologies, Inc., dated May 27, 2026

104

Cover
Page Interactive Data File (embedded within the XBRL document)

- 2 -